Author

Francisco Mesonero Gismero 1

1 Hospital Universitario Ramón y Cajal,Madrid,Spain;;

EFFECTIVENESS AND SAFETY OF VEDOLIZUMAB IN INFLAMMATORY BOWEL DISEASES

Maria Chaparro Sanchez, Ana Garre, Elena Ricart, Marisa Iborra, Francisco Mesonero Gismero, Maria Vera, Sabino Riestra Menéndez, V García-Sánchez, Luisa de Castro, A Martin-Cardona, Xavier Aldeguer, M Mínguez, Manuel Barreiro de-Acosta, Montserrat Rivero, F Muñoz, Montserrat Andreu, A Bargallo, E García-Planella, J. L. Pé

INCIDENCE AND RISK FACTORS ASSOCIATED WITH RECURRENCE OF CROHN´S DISEASE AFTER DEFINITIVE PANPROCTOCOLECTOMY AND ILEOSTOMY: THE IFARPI STUDY

Marta Isabel Calvo Moya, Gerard Suris Marin, Agnes Fernandez Clotet, Maria Amparo Aguas Peris, Yolanda Rodríguez Diaz, Cristina Suárez Ferrer, Ignacio Iborra Chaqués, María José Casanova, Carlos Gonzalez Muñoza, Beatriz Sicília Aladrén, Estela Fernández-Salgado, Andres Castaño García, Laura Jiménez Márquez, Cristina Calviño Su

INFLAMMATORY BOWEL DISEASE (IBD) AND IMMUNOSUPPRESSION DO NOT WORSEN THE PROGNOSIS OF COVID-19. RESULTS FROM THE ENEIDA PROJECT OF GETECCU

Yamile Zabana Abdo, Maria Isabel Vera Mendoza, Iván Guerra, Olga Benítez, Iago Rodríguez-Lago, Francisco Mesonero Gismero, Ignacio Marín-Jiménez, Javier Gisbert, María Dolores Martín-Arranz, Angel Ponferrada Diaz, Pilar Martínez-Montiel, Maia Boscá-Watts, Teresa Pérez-Martínez, Cristina Rodríguez Gutiérrez, Santiago Martínez-

LOW ADHESION TO LATENT TUBERCULOSIS (TB) SCREENING RECOMMENDATIONS IN INFLAMMATORY BOWEL DISEASE (IBD) PATIENTS: RESULTS OF THE INFEII REGISTRY OF GETECCU

Yamile Zabana Abdo, Ruth De Francisco Garcia, Iago Rodríguez-Lago, Maria Chaparro Sanchez, Fernando Gomollón Garcia, Marta Piqueras Cano, Jordina Llaó Guárdia, Beatriz Sicília Aladrén, Eugeni Domenech Morral, Orlando Garcia-Bosch, Luisa de Castro, Xavier Calvet Calvo, VÍctor Jair Morales Alvarado, Montserrat Rivero Tirado, Al

Real life experience of first line anti-TNF in Crohn´s disease patients in Spain: do we have data to choose between infliximab and adalimumab?

Ignacio Marín-Jiménez, Guillermo Bastida, Ana Fores, Federico Argüelles-Arias, Ignacio Tagarro, Alonso Fernandez, Carmen Montoto Otero, Mariam Aguas, Rocio Ferreiro Iglesias, Olga Merino, Javier Santos Fernandez, Xavier Cortés, Francisco Mesonero Gismero, Manuel Barreiro de Acosta

SAFETY OF VEDOLIZUMAB AND USTEKINUMAB IN ELDERLY IBD PATIENTS: A REAL-LIFE MULTICENTRIC COHORT STUDY

Cara De Galan, Harald Peeters, Francisco Mesonero Gismero, Marie Truyens, Ainara Elorza, Paola Torres, Liv Vandermeulen, Aranzazu Jauregui Amezaga, Rocío Ferreiro-Iglesias, Yamile Zabana, Tom Holvoet, Laia Peries Reverter, Jeroen Geldof, Triana Lobaton, Martine De Vos

Thiopurine withdrawal during sustained clinical remission in Crohn's disease

Ruben Sanchez-Aldehuelo, Eugenia Sanchez Rodriguez, Enrique Rodríguez de Santiago, Francisco Mesonero Gismero, Cristina Fernandez, Agustin Albillos, Antonio Lopez-Sanroman.

Item 1 - 7 / 7
1